A novel metric for treatment durability in clinical trials of minimally invasive treatments for benign prostatic hyperplasia.

ABSTRACTIntroduction: Clinical trial manuscripts commonly report results of individual endpoints. However, durability of a medical treatment may be difficult to determine when evaluating endpoint o...